| __timestamp | Bausch Health Companies Inc. | Sanofi |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 4667000000 |
| Thursday, January 1, 2015 | 582800000 | 5082000000 |
| Friday, January 1, 2016 | 455000000 | 5232000000 |
| Sunday, January 1, 2017 | 366000000 | 5567000000 |
| Monday, January 1, 2018 | 414000000 | 6350000000 |
| Tuesday, January 1, 2019 | 471000000 | 6018000000 |
| Wednesday, January 1, 2020 | 452000000 | 5529000000 |
| Friday, January 1, 2021 | 465000000 | 5692000000 |
| Saturday, January 1, 2022 | 529000000 | 6706000000 |
| Sunday, January 1, 2023 | 604000000 | 6728000000 |
| Monday, January 1, 2024 | 7394000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Sanofi and Bausch Health Companies Inc. have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Sanofi consistently outpaced Bausch Health, investing nearly 12 times more in R&D by 2023. Sanofi's R&D spending grew from approximately $4.67 billion in 2014 to $6.73 billion in 2023, reflecting a robust commitment to innovation. In contrast, Bausch Health's R&D investment, while increasing from $246 million to $604 million over the same period, remains modest in comparison. This disparity highlights Sanofi's strategic focus on long-term growth through innovation, while Bausch Health adopts a more conservative approach. As the pharmaceutical industry continues to advance, these investment trends may shape the future landscape of healthcare solutions.
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and BioMarin Pharmaceutical Inc.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Sanofi and Supernus Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
R&D Spending Showdown: Incyte Corporation vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for CRISPR Therapeutics AG and Bausch Health Companies Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.